Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Victor Ortega (Winston-Salem, United States of America), Victor Ortega, Xingnan Li, Wanda O’Neal, R. Graham Barr, David Couper, Meilan Han, Richard Kanner, Eric Kleerup, Fernando Martinez, Stephen Peters, Stephen Rennard, Prescott Woodruff, Eric Hoffman, Deborah Meyers, Eugene Bleecker. LATE-BREAKING ABSTRACT: Effects of rare SERPINA1 variants on emphysema and airtrapping in SPIROMICS. Eur Respir J 2016; 48: Suppl. 60, 1214

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: DS102: A bioactive lipid for the treatment of chronic pulmonary disorders Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: Plasma MMP-9 is related to a bronchitic COPD phenotype–report from the obstructive lung disease in northern Sweden (OLIN) studies Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Activity limitation and exacerbations in smokers with emphysema on CT but preserved pulmonary function. SPIROMICS Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 LATE-BREAKING ABSTRACT: Evaluation of symptoms and risk on stable chronic obstructive pulmonary disease patients with radiographic bronchiectasis Source: International Congress 2014 – Predictors Year: 2014 LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: An algorithm for the identification of clinical COPD phenotypes in daily practice Source: International Congress 2016 – COPD diagnosis and management Year: 2016 LATE-BREAKING ABSTRACT: A novel approach for identifying patients with undiagnosed clinically-significant COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 CAT in COPD phenotypes (POPE study) Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Small airway obstruction involvement in COPD severity Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Early phenotypes of chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Different data in COPD Year: 2015 LATE-BREAKING ABSTRACT: A novel and short-term mouse model of chronic obstructive pulmonary disease Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016